---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-032360"
form_type: "8-K"
ticker: "CODX"
cik: "0001692415"
company_name: "Co-Diagnostics, Inc."
filed_at: "2021-12-23T23:59:59+00:00"
generated_at: "2026-06-27T22:37:11.087837+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Co-Diagnostics acquires Idaho Molecular and Advanced Conceptions for up to 4.72M shares and warrants

## Summary
- Total consideration: up to 4.72M shares of CODX common stock and 465,000 warrants at $9.125 exercise price.
- Acquisition provides all existing and future assets and IP for at-home/point-of-care PCR device (Eikon/YourTest).
- Closings expected by December 31, 2021; each target becomes wholly owned subsidiary of CODX.
- Dr. Kirk Ririe to become president of subsidiary; Dr. Carl Wittwer named Chairman of Scientific Advisory Board.
- CODX commits to fund development; deal streamlines commercialization and avoids future royalties.

## SEC filing metadata
- accession: 0001493152-21-032360
- form_type: 8-K
- ticker: CODX
- cik: 0001692415
- company_name: Co-Diagnostics, Inc.
- filed_at: 2021-12-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1692415/000149315221032360/0001493152-21-032360-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1692415/000149315221032360/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-032360
- JSON: https://secwatch.observer/filing/0001493152-21-032360.json
- Plain text: https://secwatch.observer/filing/0001493152-21-032360.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.